Login / Signup
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.
Markus Hoffmann
Simon Schroeder
Hannah Kleine-Weber
Marcel A Müller
Christian Drosten
Stefan H Pöhlmann
Published in:
Antimicrobial agents and chemotherapy (2020)
Keyphrases
</>
sars cov
respiratory syndrome coronavirus
coronavirus disease